Could ketamine be the key to ending daily headaches?
NCT ID NCT05306899
First seen Nov 17, 2025 · Last updated May 16, 2026 · Updated 15 times
Summary
This study tests whether a single high-dose intravenous ketamine infusion can reduce the number and severity of headache days in people with chronic daily headaches. About 56 adults will receive either ketamine or a placebo (saline) and be followed for three months. The goal is to see if ketamine can safely provide lasting relief from this debilitating condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC DAILY HEADACHE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Toronto Western Hospital
RECRUITINGToronto, Ontario, M5T 2S8, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Women's College Hospital
RECRUITINGToronto, Ontario, M5S 1B2, Canada
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.